Katherine Forsey

Dr Katherine Forsey leads the Strategy To Accelerate Research (STAR) at the Charcot-Marie-Tooth Association (CMTA), driving a global, patient-focused agenda to develop treatments for CMT. She oversees a portfolio of more than 50 active research programmes, coordinates the CMTA-STAR Advisory Board, and serves as a key interface for biotech, pharmaceutical, and academic partners. She also curates the Patients as Partners in Research platform, ensuring the CMT community is meaningfully embedded in the design and delivery of therapeutic development. Katherine is a PhD-trained research biologist, with academic experience at the University of York, the University of Cambridge, and the Czech Veterinary Research Institute, alongside industry experience at Syngenta. Prior to joining CMTA in 2022, she held senior roles spanning science, education, and industry, and founded a consultancy focused on translating science into programmes, partnerships, and real-world implementation. Based in England,